Hemab Therapeutics Holdings, Inc. (COAG)
Market Closed
10 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
49. 87
+0.21
+0.4229%
$
100.18M Market Cap
- P/E Ratio
- Div Yield
292,181 Volume
- Eps
$ 49.66
Previous Close 
Analysts:
Want to track COAG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hemab Therapeutics Holdings, Inc. (COAG) Statistics
Valuation metrics
Market Cap 100.18M
Enterprise value 13M
Trailing P/E (ttm) -21.31
Forward P/E -
PEG ratio -0.21
Price/Sales (ttm) -
Price/Book (mrq) -7.72
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.19
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 583.46K
Average volume (90 days) 263.62K
Price summary
52-Week low 23
52-Week high 53.61
Beta -
50-Day moving average 41.27
200-Day moving average 30.62
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.33%
Return on equity 0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.76
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 18.03%
Book value per share (mrq) -6.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
